Combinations of Kinase Inhibitors Protecting Myoblasts against Hypoxia

Yunyi Kang1, Matthew Tierney1, Edison Ong2

  • 1Sanford-Burnham Medical Research Institute, La Jolla, California, United States of America.

Plos One
|June 5, 2015
PubMed

Insights

Kinase inhibitors protect transplanted muscle cells from hypoxic stress, improving survival for skeletal muscle disease therapies. CDK5 plays a key role in this cell protection mechanism.

Area of Science:

  • Biomedical Sciences
  • Cell Biology
  • Pharmacology

Background:

  • Cell-based therapies for skeletal muscle disease face challenges due to poor donor myoblast survival.
  • Acute hypoxic stress in the transplantation microenvironment is a major contributor to myoblast cell death and growth arrest.

Purpose of the Study:

  • To identify kinase inhibitors that enhance myoblast survival under hypoxic conditions.
  • To investigate the role of specific kinases, particularly CDK5, in protecting myoblasts against hypoxia.
  • To develop and validate computational methods for predicting drug efficacy and combinations.

Main Methods:

  • Screening of a kinase inhibitor library to identify compounds protecting myoblasts from hypoxia-induced cell death.
  • Combinatorial studies of identified inhibitors to assess synergistic and additive effects on myoblast viability.
  • Pathway and target analysis to identify key kinases, including CDK5, CDK2, CDC2, WEE1, and GSK3β.
  • Computational validation using elastic net regression to confirm the role of CDK5 and predict optimal inhibition levels.

Main Results:

  • Five kinase inhibitors were identified that significantly protected myoblasts from hypoxic stress.
  • Combinatorial treatment with these inhibitors further improved myoblast viability, demonstrating synergistic and additive effects.
  • CDK5 was identified as a central kinase in the protective network, with CDK2, CDC2, WEE1, and GSK3β also implicated.
  • A novel statistical method computationally validated CDK5's role and predicted optimal drug combinations.

Conclusions:

  • Kinase inhibitors represent a promising strategy to improve the survival of transplanted myoblasts in hypoxic environments.
  • Targeting specific kinases, especially CDK5, can mitigate hypoxic damage and enhance the efficacy of cell-based therapies for skeletal muscle diseases.
  • The developed computational methods offer a powerful tool for drug discovery and optimization in the context of hypoxic stress.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Hypoxia01:23

Hypoxia

Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
2.6K
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
21.7K